Found 9 matching trials
PF-06741086 Multiple Dose Study in Severe Hemophilia
PHASE2This study is designed to evaluate the safety, tolerability, pharmacokineti...
Location
UC Denver Hemophilia and Thrombosis Center - Pharmacy
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
PHASE3The purpose of this clinical trial is to learn about the safety and effects...
Location
Intermountain - Primary Children's Hospital
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
PHASE3Treatment with PF-06741086 is anticipated to demonstrate a clinically relev...
Location
USF Health Morsani Center For Advanced Healthcare
A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device
PHASE1The goal in this study is to show that there are not significant difference...
Location
Brussels Clinical Research Unit
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
PHASE3Study B7841007 is an open-label extension study to assess the long-term saf...
Location
University of Iowa
Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia
PHASE1This Phase 1 study will be a single-arm, open-label, non-randomized, non-co...
Location
Institute of Hematology, Chinese Academy of Medical Sciences
A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
PHASE1The purpose of the study is to learn about safety, how the body processes m...
Location
Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center
Dose Escalation Study of PF-06741086 In Healthy Subjects
PHASE1This Phase 1 first-in-human single ascending dose study will be a randomize...
Location
Pfizer Clinical Research Unit
PF-06741086 Long-term Treatment in Severe Hemophilia
PHASE2This study is designed to evaluate the safety, tolerability and efficacy of...
Location
UC Denver Hemophilia and Thrombosis Center